This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: City University of Hong Kong, The Hong Kong Polytechnic University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: Yang Liu: Innovator in Microfluidic Technology
Introduction
Yang Liu is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of microfluidics, particularly in developing devices that enhance biomedical research. His innovative approach has led to advancements in understanding wound infections and their implications.
Latest Patents
Yang Liu holds a patent for a microfluidic-based device designed for in vivo wound infection models. The patent, titled "Microfluidic-based device for in vivo wound infection model and uses thereof," provides an integrated solution for establishing wound infection models suitable for high-throughput bioassays. This invention allows for direct qualitative and quantitative assessments of specific markers expressed due to wound infections, eliminating the need for cell sorting, isolation, or labeling, which are common in conventional methods.
Career Highlights
Throughout his career, Yang Liu has worked with esteemed institutions such as The Hong Kong Polytechnic University and City University of Hong Kong. His work has focused on enhancing the understanding of host-microbe interactions and the regulatory mechanisms of inflammatory diseases related to wound infections.
Collaborations
Yang Liu has collaborated with notable colleagues, including Song Lin Chua and Bee Luan Khoo. These partnerships have contributed to the advancement of research in the field of microfluidics and its applications in biomedical science.
Conclusion
Yang Liu's innovative contributions to microfluidic technology have paved the way for new research methodologies in understanding wound infections. His work exemplifies the importance of innovation in advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile